NewsShow news

Cerenion granted funding for a 222,000€ project by the European Union

27th of March 2018
Cerenion Oy to receive significant funding from the European Regional Development Fund of the European Union.
The grant for a project of approximately 222,000€ has been awarded for the development of an ISO13485 -certified Quality Management System, and the related work in seeking the appropriate regulatory approvals and bringing the Cerenion C-Trend™ index to the international market. The non-dilutive funding will assist Cerenion in bringing its innovative brain monitoring technology to market in the European Union in the near future.
''We are grateful to the ERDF, the European Union and the Centre for Economic Development, Transport and the Environment in North Ostrobothnia for this grant. Aided by the grant we feel confident that we can bring our novel solution to the healthcare market in due time and really make a difference in the care of ICU patients.'', says Dr. Timo Koskela, CEO of Cerenion.
Read more about the support .

Would you like to know more?

We would be happy to tell you more about our technology, and talk about possible avenues of collaboration. So please don't hesitate to contact us for more information.

Contact us

Dr. Timo Koskela, CEO
tel. +358 40 5773 706

Visit us

Cerenion Oy
Elektroniikkatie 3
90590 Oulu
Teknobulevardi 3-5
01530 Vantaa
This website and all of the content therein is for reference purposes only and is not intended to substitute for advice from a licensed healthcare professional. Under no circumstances shall the information on this website be construed as an advertisement of any commercially available product. Cerenion™, Cerenion C-Trend™, C-Trend™, ''The next-generation brain monitoring company''™ and ''The pulse of the brain''™ are trademarks of Cerenion Oy. Cerenion technology is covered by Intellectual Property Rights. Patents pending worldwide. All rights reserved. © Cerenion Oy 2017.